Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,004,306
-$1,005,078 QoQ
Shares Held
110,353
-32.5% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#157
of 739 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Engineers Gate Manager LP holds $195,993,154 across 162 Biotechnology names. EXEL ranks #6 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
126,044 | $13,438,811 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
181,647 | $10,393,841 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
33,469 | $10,075,173 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,918 | $9,925,509 | |
| 5 | RPRX |
Royalty Pharma plc
|
137,994 | $7,737,323 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
110,353 | $6,004,306 | |
| 7 | ONC |
BeOne Medicines Ltd.
|
16,302 | $4,645,580 | |
| 8 | VERA |
Vera Therapeutics, Inc.
|
108,139 | $4,640,244 |
All Filings in EXEL
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,004,306 | 110,353 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $7,009,384 | 163,427 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,044,337 | 23,827 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,914,947 | 119,006 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,548,440 | 80,500 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $3,087,009 | 92,703 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,689,769 | 103,652 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,960,934 | 87,269 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,491,928 | 62,871 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,305,079 | 54,401 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,823,107 | 129,204 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,376,309 | 124,349 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,097,363 | 56,536 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $984,503 | 61,378 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,629,943 | 167,726 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $896,863 | 43,077 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $425,855 | 18,785 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $505,112 | 27,632 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,248,972 | 59,081 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,855,670 | 101,848 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,446,889 | 64,050 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,036,093 | 51,624 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $316,872 | 12,960 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,184,388 | 49,890 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $741,889 | 43,083 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||